Withdrawn application: Amyvid, 26/02/2025

Annex V - List of hydroxyethyl starch (HES)-containing medicinal products in the European Union

List of medicinal products under additional monitoring

List of medicinal products under additional monitoring

List of European Union reference dates (EURD) and frequency of submission of periodic safety update reports (PSURs)

EMA closed 29-30 May

Human medicines European public assessment report (EPAR): Galafold, migalastat, Date of authorisation: 25/05/2016, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR): Icandra (previously Vildagliptin / metformin hydrochloride Novartis), vildagliptin,metformin, Date of authorisation: 30/11/2008, Revision: 28, Status: Authorised

Human medicines European public assessment report (EPAR): Eucreas, vildagliptin,metformin, Date of authorisation: 14/11/2007, Revision: 26, Status: Authorised

Human medicines European public assessment report (EPAR): Paxlovid, nirmatrelvir,ritonavir, Date of authorisation: 28/01/2022, Revision: 27, Status: Authorised